Skip to Content

Ostora Approval Status

FDA Approved: No
Brand name: Ostora
Generic name: calcitonin
Company: Tarsa Therapeutics
Treatment for: Osteoporosis

Ostora (calcitonin) is an oral recombinant salmon calcitonin formulation in development for the treatment of postmenopausal osteoporosis.

Development Status and FDA Approval Process for Ostora

DateArticle
Dec 13, 2011Tarsa Therapeutics Targets 2012 NDA Submission for its Ostora Oral Calcitonin

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide